已关闭
收藏名称 卡格列肽 | 分子结构式 |
CAS号 1415456-99-3 | |
分子量 4409.01 | |
分子式 C194H312N54O59S2 | |
短序列号 {Eicosanedioic acid-γ-Glu}-KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH2 (Disulfide bridge:Cys3-Cys8) | |
序列号 {Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 (Disulfide bridge:Cys3-Cys8) | |
国际标识符代码 LDERDVMBIYGIOI-IZVMHKDJSA-N | |
纯度 ≥98% | |
药理学 Canaglitide is a peptide hormone that is mainly used to treat diabetes. It lowers blood sugar and controls blood sugar levels. | |
作用靶点 CGRP Receptor | |
水中溶解度 ≥ 100 mg/mL | |
引用文献 [1]. Fletcher MM, et al. AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists. J Pharmacol Exp Ther. 2021 Jun;377(3):417-440. [2]. Kruse T, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem. 2021 Aug 12;64(15):11183-11194. [3]. Dehestani B, et al. Amylin as a Future Obesity Treatment. J Obes Metab Syndr. 2021 Dec 30;30(4):320-325. | |